Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on CSL.
RELATED STOCKHEAD STORIES
News
ASX Small Cap Lunch Wrap: Local markets limp as Delta and Voltaic make lithium love at Ti Tree
News
Market Highlights: Wall St and Nvidia went all Icarus on Friday… is the ASX wearing enough sunscreen??
Health & Biotech
ScoPo’s Powerplays: ASX health stocks flat in ‘up and down’ reporting season
Experts
Dr Boreham’s Crucible: Don’t have a heart attack, CSL’s profit-making ability is in the blood
Health & Biotech
ScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpoint
News
Closing Bell: Big caps get whacked on ASX Day of the Earnings Miss
News
ASX Large Caps: Seek, Breville dumped on soft results; Strike Energy crashes 23pc
News
ASX Small Caps Lunch Wrap: Who’s been busted ‘wasting police time’ this week?
News
ASX Large Caps: Audinate gains 20pc to all-time high, JB Hi-Fi says retail demand still strong
News
ASX Small Caps Lunch Wrap: Is the world ready for a terrifying hybrid stingray shark?
Health & Biotech
ASX Health Stocks: CSL’s Phase 3 AEGIS-II trial disappoints, fails to meet primary efficacy endpoint
Health & Biotech
ScoPo’s Powerplays: ASX health stocks up as Cochlear upgrades earnings guidance
News
Closing Bell: ASX investors abandon ship after eight straight days on a sea of green
Health & Biotech
ScoPo’s Powerplays: ASX healthcare 0.3% up as focus shifts to M&A activity in 2024
Experts
Confessions of a Day Trader: Battling low volume and more swing than a prime Wasim Akram
Closing Bell: Super Sigma lifts benchmark after oil saps energy stocks
News